| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/24/2011 | US20110046183 Crystal of benzimidazole compound |
| 02/24/2011 | US20110046182 Efficient aspirin prodrugs |
| 02/24/2011 | US20110046179 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/24/2011 | US20110046174 Kappa-opiate agonists for the treatment of diarrhea-predominant irritable bowel syndrome |
| 02/24/2011 | US20110046170 Novel pyrimidine-pyridine derivatives |
| 02/24/2011 | US20110046166 Purine derivatives as a3 adenosine receptor-selective agonists |
| 02/24/2011 | US20110046151 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 02/24/2011 | US20110046148 Spirocyclic Heterocycles Medicaments Containing Said Compounds, Use Thereof And Method For Their Production |
| 02/24/2011 | US20110046137 Pyrazole Derivatives as P2X7 Modulators |
| 02/24/2011 | US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 02/24/2011 | US20110046131 Purines as pkc-theta inhibitors |
| 02/24/2011 | US20110046130 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists |
| 02/24/2011 | US20110046129 2-Phenylethylamino Derivatives as Calcium and/or Sodium Channel Modulators |
| 02/24/2011 | US20110046122 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines |
| 02/24/2011 | US20110046118 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| 02/24/2011 | US20110046113 Amine compound and use thereof |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046106 Aryl sulfonamides as effective analgesics |
| 02/24/2011 | US20110046097 Substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/24/2011 | US20110046096 Novel piperazino-dihydrothienopyrimidine derivatives |
| 02/24/2011 | US20110046081 Classical cannabinoid metabolites and methods of use thereof |
| 02/24/2011 | US20110046075 Secreted Staphylococcus Aureus Proteins And Peptides For Use In Inhibiting Activation Of The Complement System |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110046069 Uses of Modified ELR-CXC Chemokine G31P |
| 02/24/2011 | US20110045590 Calcium-influx inhibitory factor and method of isolation thereof |
| 02/24/2011 | US20110045106 Coffee extract |
| 02/24/2011 | US20110045099 Nutraceutical composition and methods of use |
| 02/24/2011 | US20110045080 Single-Walled Carbon Nanotube/Bioactive Substance Complexes and Methods Related Thereto |
| 02/24/2011 | US20110045056 Hydrogel co-polymer composition and its uses, for example as a wound dressing |
| 02/24/2011 | US20110045010 Anti-lps factor from parietaria judaica and methods of use thereof |
| 02/24/2011 | US20110045007 Fusion or linked proteins with extended half life |
| 02/24/2011 | US20110045004 Method for in-vitro detecting pathogenic t helper cells and pharmaceutical compositions for treating autoimmune diseases |
| 02/24/2011 | US20110045003 Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders |
| 02/24/2011 | US20110045002 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 02/24/2011 | US20110045001 Transfection results of non-viral gene delivery systems by influencing of the innate immune system |
| 02/24/2011 | US20110045000 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/24/2011 | US20110044997 Methods |
| 02/24/2011 | US20110044996 Neutralizing antibodies |
| 02/24/2011 | US20110044990 Antibody design using anti-lipid antibody crystal structures |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044929 Formulations and methods for treatment of inflammatory diseases |
| 02/24/2011 | US20110044917 Dental composition for treating peri-implantitis |
| 02/24/2011 | DE112008003232T5 Antigen-Bindungskonstrukte Antigen-binding constructs |
| 02/24/2011 | CA2771257A1 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | CA2769409A1 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287156A1 2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/23/2011 | EP2286827A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2286799A2 Microspheres for active embolization |
| 02/23/2011 | EP2286798A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 02/23/2011 | EP2286793A2 Pharmaceutical formulations comprising cannabidiol |
| 02/23/2011 | EP2285794A2 Chromane derivatives as trpv3 modulators |
| 02/23/2011 | EP2285780A1 Processes and compounds for the preparation of normorphinans |
| 02/23/2011 | EP2285449A2 Sparc anti-inflammatory activity and uses thereof |
| 02/23/2011 | EP2285371A2 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds |
| 02/23/2011 | EP2285363A2 Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
| 02/23/2011 | EP2285244A1 Sialic acid to support the immune system in the elderly |
| 02/23/2011 | EP2155721B1 Organic compounds |
| 02/23/2011 | EP1831257B1 Humanized antibody specific for tumor necrosis factor-alpha |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1268096B2 Extrusion die |
| 02/23/2011 | EP1135504B1 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 02/23/2011 | CN1980664B CRTH2 receptor ligands for therapeutic use |
| 02/23/2011 | CN1934252B Thrombin derivatives and medicinal composition containing the same |
| 02/23/2011 | CN1751042B Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 02/23/2011 | CN101981030A Dihydro- 1H- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as S1P1 agonists |
| 02/23/2011 | CN101981012A Novel tetrahydroisoquinoline derivative |
| 02/23/2011 | CN101980705A Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 02/23/2011 | CN101980703A Self-destructing transdermal therapeutic system having improved functionality and efficacy |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979366A Diarylheptanoid compounds in curcuma zedoary and medicinal application thereof |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/23/2011 | CN101979093A Composition comprising polypeptide-drug substance and other poorly absorbed active ingredient and its use |
| 02/23/2011 | CN101979087A Health liquor and preparation method thereof |
| 02/23/2011 | CN101979083A External Chinese medicinal bag for treating scapulohumeral periarthritis |
| 02/23/2011 | CN101979081A Plaster for treating arthritis and hyperosteogeny |
| 02/23/2011 | CN101979074A Traditional Chinese medicine for treating rheumatoid arthritis |
| 02/23/2011 | CN101979069A Method for preparing drill yamakaze syrup |
| 02/23/2011 | CN101979036A Medicinal liquor for treating rheumatic arthritis |
| 02/23/2011 | CN101979033A Detoxification and network vessel-freeing capsules |
| 02/23/2011 | CN101979026A Moisture-nourishing menstruation-regulating umbilical plaster |
| 02/23/2011 | CN101979025A Prescription of blood circulation invigorating and pain stopping plaster and preparation method |
| 02/23/2011 | CN101978997A Externally-applied cream for treating wind-heat cold by adopting transdermal absorption technology |
| 02/23/2011 | CN101978978A Solution with effect of repairing exercise-induced skeletal muscle microdamage |
| 02/23/2011 | CN101978963A Annonaceous acetogenin extract, preparation method thereof and use thereof in cancer resistance and relief of cancerous pain |
| 02/23/2011 | CN101978960A Application of naphthalimide derivative as immunosuppressant |
| 02/23/2011 | CN101978955A Dextral ibuprofen amino acid salt tablets and preparation method thereof |
| 02/23/2011 | CN101978951A 9,10-diphenylanthracene(DPA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 02/23/2011 | CN101978950A Alpha-linolenic acid ester fat emulsion injection and preparation method thereof |
| 02/23/2011 | CN101978945A 一种布洛芬药物组合物 One kind of ibuprofen pharmaceutical composition |
| 02/23/2011 | CN101978864A Rape bee-pollen extract and use thereof |
| 02/22/2011 | US7893280 2,4-disubstituted thiazolyl derivatives |
| 02/22/2011 | US7893279 Cyclohexanecarboxylic acid compound |
| 02/22/2011 | US7893242 Oligonucleotide compositions and their use to induce apoptosis |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893112 N-(1-cyanocyclopropyl)-4,4-difluoro-2(S)-[2,2,2-trifluoro-1(S)-(4-fluorophenyl)ethylamino)octamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, lupus, asthma, pain, atherosclerosis; cathepsins B, K, L, F, and S inhibitors |